Rivaroxaban versus enoxaparin after total knee arthro... [Lancet. 2009] - PubMed

Save items

loading

Related citations in PubMed

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. [Lancet. 2009]
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, et al. Lancet. 2009 May 16; 373(9676):1673-80. Epub 2009 May 4.
Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. [Eur J Clin Pharmacol. 2010]
Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
Cao YB, Zhang JD, Shen H, Jiang YY. Eur J Clin Pharmacol. 2010 Nov; 66(11):1099-108. Epub 2010 Sep 2.
Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery. [Clin Appl Thromb Hemost. 2009]
Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
Van Thiel D, Kalodiki E, Wahi R, Litinas E, Haque W, Rao G. Clin Appl Thromb Hemost. 2009 Jul-Aug; 15(4):389-94. Epub 2009 Jul 15.
Review Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials. [Croat Med J. 2010]
Review Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials.
Trkulja V, Kolundzic R. Croat Med J. 2010 Apr; 51(2):113-23.
Review Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery. [Drugs. 2009]
Review Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Duggan ST, Scott LJ, Plosker GL. Drugs. 2009; 69(13):1829-51.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. [BMJ. 2012]
Review Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.
Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea ML, Vargas-Castrillón E. BMJ. 2012 Jun 14; 344:e3675. Epub 2012 Jun 14.
Review New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. [Vasc Health Risk Manag. 2012]
Review New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
Dahl OE. Vasc Health Risk Manag. 2012; 8:45-57. Epub 2012 Jan 25.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Rivaroxaban versus enoxaparin after total knee arthroplasty.
Rivaroxaban versus enoxaparin after total knee arthroplasty.
Lancet. 2009 Aug 29 ;374(9691):682; author reply 683. doi: 10.1016/S0140-6736(09)61552-X.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Rivaroxaban versus enoxaparin after total knee arthroplasty.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information